Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
138,961,039
-
Total 13F shares
-
4,906,563
-
Share change
-
-1,265,675
-
Total reported value
-
$5,445,185
-
Put/Call ratio
-
7.7%
-
Price per share
-
$1.11
-
Number of holders
-
57
-
Value change
-
-$3,025,598
-
Number of buys
-
28
-
Number of sells
-
39
Institutional Holders of Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) as of Q1 2024
As of 31 Mar 2024,
Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,906,563 shares.
The largest 10 holders included
VANGUARD GROUP INC, GSA CAPITAL PARTNERS LLP, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, Cetera Investment Advisers, STATE STREET CORP, NORTHERN TRUST CORP, and XTX Topco Ltd.
This page lists
57
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.